0:00Welcome to Base by Base, the paper cast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. So today we're diving into a really fundamental question, one that sort of redefines how we look at cancer progression.
0:14Yeah, specifically in melanoma, which is one of the deadliest skin cancers out there. For decades, you know, when a cancer turns lethal, when it gets resistant to drugs, we immediately look for a genetic mistake.
0:26A new mutation, something in the DNA. Exactly. But what if one of the biggest drivers of that deadly switch isn't a gene at all? What if it's something as well, as simple as just being squeezed? That's the whole idea of plasticity.
0:40Right. This remarkable ability of a cancer cell to just switch its entire job description. It's phenotype. And in melanoma, that switch is, I mean, it's literally the difference between life and death.
0:50So that's a big question for you. If a tumor cell is being physically confined, you know, crushed by the tissue around it, what's its emergency response? And how could that simple physical force completely rewrite its playbook?
1:03Making it aggressive, mobile, and totally impervious to our best drugs, that's the powerful connection we're going to unpack in this deep dive. It's fascinating story. Before we jump into the details, we really have to recognize the sheer scale of this investigation.
1:19Oh, absolutely. Connecting a physical force to a molecular change like this is no small feat. So today, we're celebrating the work of teams primarily based at Memorial Sloan Kettering Cancer Center, but also with huge contributions from the University of Oxford and NYU Lengon Health.
1:36They used a truly multiscale approach to prove how these mechanical forces really do reshape cancer. So set the stage for us. What's the core scientific problem they were tackling here? It all comes down to phenotype switching in melanoma.
1:50We've known for a long time that these cells can switch between two extremes. Okay, what are the 2 extremes? So on one side, you have the proliferative cell? This one is busy growing, making copies of itself.
2:00It has high levels of differentiation markers like MITF. And that's the one we can target with drugs, generally speaking. That's the one. But then you have the other side of the coin. The nightmare scenario.
2:11Exactly. The aggressive, invasive, and highly drug resistant state. And this ability to just switch hats, you know, without a new DNA mutation, that's always been a hallmark of melanoma. It's what researchers call the go or grow hypothesis, right?
2:27Precisely. The cell kind of optimizes for one behavior. You can either grow, meaning proliferate fast, or it can go, meaning move and invade. But it rarely does both well at the same time. Oh, it's a trade-off.
2:41So wait, is that why treating early stage melanoma is often successful because the cells are still in that grow phase? You've got it. The moment that switch gets flipped, the cancer changes. It goes from being a manageable superficial tumor to that deadly invasive form.
2:55The form that resists even our best immunotherapies. And that's why finding the trigger, the cue from the tumor microenvironment that flips that switch has been the holy grail. And the hypothesis was that physical pressure had to be one of those cues.
3:08It was, but proving it was the really hard part. Okay, so let's talk about how they proved it. Their approach was incredibly clever, starting with an in vivo model. Right. They used a transgenic zebrafish.
3:21A zebra fish that was engineered to get a human-like melanoma. Yes, driven by the BRA, AFE 600 E mutation, just like in many human patients, so they could watch the cancer invade in a living, breathing organism.
3:35And then they brought in the heavy duty mapping tools. Spatially resolved transcriptomics, and single cell RNA sex. And they use those tools to profile the cells right at the invasive interface. Why that interface specifically?
3:48Because that's the boundary. That's the front line where the tumor is physically pressing against the host tissue. By looking only at those cells, they could see the molecular instructions being used for the invasion.
3:59And crucially, this wasn't just in fish. No, and that's so important. They cross-referenced everything with a huge public data set from 31 human melanoma patients. Many of whom had become resistant to therapy.
4:11Which is what really validated the whole study in a human context. But the real clincher was isolating the pressure itself. Cause from correlation. Exactly. For that, they used a beautiful in vitro confinement system.
4:24They took human melanoma cells, and, well, they physically squashed them. Using a polished piston made of PDMS, I think? That's right. Polyamethyl sylloxane. And when you say squashed, you mean extreme confinement.
4:36Yeah, they were defining the space down to only 3 micrometers high. Three micrometers. I mean, just to put that in perspective for everyone, that is 30 times thinner than a human hair. Wow. So they were forcing these cells to survive under intense, very defined mechanical pressure.
4:53So what did they see? What did the cells actually look like under all that stress? Well, that's where the findings get really interesting. First, just their shape told the story. Their morphology. Right.
5:02The cells at that invasive interface, in both the zebra fish and the human samples, had these highly elongated elliptical nuclei. That stretched out shape is the classic signature of a cell under intense pressure.
5:14They were literally being distorted. And that physical distortion caused a profound molecular identity crisis. The squeezed cells fired up a gene program linked to an undifferentiated state. So they were losing their original identity as pigment cells.
5:29They were. But here's the really surprising twist. They started adopting markers that are normally associated with neuronal development. Neuronal development. You mean like nerve cells? Exactly, like nerve cells.
5:42Why on earth would a cancer cell want to act like a neuron? It's a brilliant survival tactic when you think about it. Neurons and the neural crest cells they come from are absolute masters of migration.
5:54Ah, of sensing their environment and moving through it. Precisely. So genes like SOX 11 and neurod one, which basically govern how the nervous system is built. were highly up-regulated. The cell hijacks that program to get better at moving.
6:09Well, at the same time, shutting down the grow genes like MITF. So the squeeze flips the identity. It turns on this aggressive mobile neuronal program, but how does the cell actually survive being crushed?
6:21How does it stop its nucleus from just rupturing? That is an excellent question. It needs reinforcement, a structural fix. And they found one. They did. Confinement rapidly triggered a remodeling of the cell's internal scaffolding.
6:33The microtubule cytoskeleton. And this created what they called a cage. A stable, dense, parrinuclear, acetylated tubulant cage. It physically encircles the nucleus. So it's like a structural bodyguard.
6:46The nucleus is the biggest, stiffest thing in the cell, so it's the most vulnerable. Exactly. So the cell builds a cage around it to protect it. It's a defense mechanism. And it's similar to what actual neurons use when they migrate through tight spaces.
6:59It is. The key is tubulin acidillation. An enzyme called ATT1 handles it. And this process makes the microtubule network incredibly stiff and resistant to being broken down. Okay, so the cell builds this physical defense, but what's the molecular trigger inside the nucleus?
7:15What senses that crushing force and turns on the whole invasion program? That was the big mystery they solved. They identify the specific mediator as a DNA bending protein called HMGB 2. High mobility Group Box 2.
7:27That's the one. And it's concentration just shot up under confinement. It nearly doubled in the squeeze cells. And they could even see it visually, right? They could. They found a strong inverse correlation.
7:37The flatter and more squash the nucleus was. The higher the concentration of HMGB 2 protein was inside it. Okay, so how does that force get from outside the cell, through the cytoplasm, and signal to the nucleus to crank up HMGB2.
7:52That signal travels through a physical cable, basically, a structure called the LINC complex. Which anchors the cell's skeleton to the nucleus. Exactly. And they identified a specific protein in that complex, Nesprin 2, that was required for both HMGB 2 accumulation and for building that protective tubulant cage.
8:10So the whole system is connected. The nucleus itself even hardened. It did. Proteins like lamin AC, which give the nucleus its stiffness, increased by about threefold. So the physical stress hardens the nucleus while simultaneously flipping the genetic switch via HMGB 2.
8:26What is HMGB 2 actually doing to the DNA? Well, HMGB 2 is a DNA bender. Physically grabs onto the chromatin and under confinement, it sticks to the chromatin for much longer. And what does that do? That increased interaction?
8:38It basically unlocks the genome. It broadly increases chromat and accessibility. Like, opening up a tightly packed book. A perfect analogy. It specifically opens up the pages. The genetic loci associated with neural crest and neuronal development.
8:53It exposes the binding sites for the master regulators of invasion, like AP1 and SOX9. So each MGB 2 is physically restructuring the genome to favor this aggressive neuronal identity. That's the mechanism.
9:07Which brings us to the really profound clinical implications. Let's go back to that go or grow trade-off. Right, to prove HMGB 2 was the cause. They genetically disrupted it in the zebra fish. And the result was, I have to say, pretty counterintuitive.
9:20It was, absolutely. When they knocked out HMGB 2. The tumors grew almost twice as large. But they were significantly less invasive. So that proves it. HMGB 2 actively enforces that tradeoff. It forces the cell to start growing.
9:33And start moving. It sacrifices proliferation for invasion. That's just fascinating, but the biggest clinical threat here. has to be drug tolerance. It is. The confined HMGB 2 activated cells were resistant to chemotherapy.
9:46Specifically, to tax all. And what about targeted therapies? Even more critically in mouse models, overexpressing HMGP 2, significantly impaired the tumor's response to Deborah Finib and Trematino. And those are the standard of care drugs for BRAF mutant melanoma.
10:03The standard of care. The difference in tumor volume was clear and statistically significant. So we're really looking at a scenario where physical force isn't just a byproduct of cancer. It's a powerful epigenetic cue.
10:15It absolutely is. It drives stable changes in chromaten architecture, leading to this aggressive, drug resistant, moronal like state. The tumor adapts to being crushed by becoming tougher and moving out.
10:25That's the whole story. And while the study focused on HMDB 2's role with DNA, we know these proteins can also bind RNA. So there's probably even more to this story. More ways that these cells are hijacking neuronal programs to metastasize.
10:38So what's the central take-home message here? The insight is that mechanical pressure from the tissue around a tumor forces melanoma cells to undergo this profound switch. They willingly sacrifice growth for invasion and drug resistance.
10:51And this whole transition is orchestrated by one protein, HMGB 2, which senses the confinement, remodels the entire genome, to activate a neuronal like invasion program. And even build a protective internal cage to help it on its way.
11:05It really makes you rethink everything. I mean, if the physical landscape of the tuner, the stiffness, the pressure is what triggers lethal drug resistance. What does that mean for treatment strategies that only focus on genetic mutations and completely ignore the tumors, mechanical world?
11:19This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating.
11:34If you'd like to support our work, use the donation link in the description. Now, stay with us for an original track created especially for this episode and inspired by the article you've just heard about.
11:43Thanks for listening and join us next time as we explore more science base by base.
